Literature DB >> 8662860

Methylation of CpG island transcription factor binding sites is unnecessary for aberrant silencing of the human MGMT gene.

R O Pieper1, S Patel, S A Ting, B W Futscher, J F Costello.   

Abstract

Aberrant transcriptional inactivation of the non-X-linked human O-6-methylguanine DNA methyltransferase (MGMT) gene has been associated with loss of open chromatin structure and increases in cytosine methylation in the Sp1-binding region of the 5'-CpG island of the gene. To examine the necessity of these events for gene silencing, we have isolated and characterized a subline of human MGMT+ T98G glioma cells. The subline, T98Gs, does not express MGMT activity or MGMT mRNA, and exhibits no in vivo DNA-protein interactions at Sp1-like binding sites in the MGMT 5'-CpG island. While the MGMT CpG island is less accessible to exogenously added restriction enzymes in T98Gs nuclei than in T98G nuclei, it is similarly methylated in both T98G and T98Gs cell lines 5' and 3' to the transcription factor binding sites, and similarly unmethylated in the region encompassing the binding sites. Inappropriate transcriptional inactivation of MGMT, therefore, does not require methylation of transcription factor binding sites within the 5'-CpG island. Rather, MGMT gene silencing and transcription factor exclusion from T98Gs MGMT CpG island binding sites is most closely associated with condensed chromatin structure, which is in turn indirectly influenced by distant sites of methylation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662860     DOI: 10.1074/jbc.271.23.13916

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene.

Authors:  G S Watts; R O Pieper; J F Costello; Y M Peng; W S Dalton; B W Futscher
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Aberrant silencing of the CpG island-containing human O6-methylguanine DNA methyltransferase gene is associated with the loss of nucleosome-like positioning.

Authors:  S A Patel; D M Graunke; R O Pieper
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  Microarray analysis of promoter methylation in lung cancers.

Authors:  Masayuki Fukasawa; Mika Kimura; Sumiyo Morita; Kenichi Matsubara; Sumitaka Yamanaka; Chiaki Endo; Akira Sakurada; Masami Sato; Takashi Kondo; Akira Horii; Hiroyuki Sasaki; Izuho Hatada
Journal:  J Hum Genet       Date:  2006-01-25       Impact factor: 3.172

4.  Confluence-induced alterations in CpG island methylation in cultured normal human fibroblasts.

Authors:  R O Pieper; K A Lester; C P Fanton
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

5.  Where are we with treatment options after first line in small cell lung cancer?-report of two opposite cases treated with CAPTEM regimen and possible perspectives.

Authors:  Alessio Cortellini; Antonella Dal Mas; Katia Cannita; Guido Collina; Alessandro Parisi; Francesco Pavese; Giampiero Porzio; Lucilla Verna; Corrado Ficorella
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 6.  MGMT Status as a Clinical Biomarker in Glioblastoma.

Authors:  Madison Butler; Lorinc Pongor; Yu-Ting Su; Liqiang Xi; Mark Raffeld; Martha Quezado; Jane Trepel; Kenneth Aldape; Yves Pommier; Jing Wu
Journal:  Trends Cancer       Date:  2020-03-27

7.  The imprinted gene LRRTM1 mediates schizotypy and handedness in a nonclinical population.

Authors:  Emma L Leach; Gratien Prefontaine; Peter L Hurd; Bernard J Crespi
Journal:  J Hum Genet       Date:  2014-05-01       Impact factor: 3.172

8.  Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study.

Authors:  Terzah M Horton; Patrick A Thompson; Stacey L Berg; Peter C Adamson; Ashish M Ingle; M Eileen Dolan; Shannon M Delaney; Madhuri Hedge; Heidi L Weiss; Meng-Fen Wu; Susan M Blaney
Journal:  J Clin Oncol       Date:  2007-11-01       Impact factor: 44.544

9.  Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas.

Authors:  Sibille Everhard; Jörg Tost; Hafida El Abdalaoui; Emmanuelle Crinière; Florence Busato; Yannick Marie; Ivo G Gut; Marc Sanson; Karima Mokhtari; Florence Laigle-Donadey; Khê Hoang-Xuan; Jean-Yves Delattre; Joëlle Thillet
Journal:  Neuro Oncol       Date:  2009-02-17       Impact factor: 12.300

10.  The promoter methylation status of the DNA repair gene O6-methylguanine-DNA methyltransferase in ulcerative colitis.

Authors:  Shunji Matsumura; Naohide Oue; Reiko Ito; Hirofumi Nakayama; Yasuhiko Kitadai; Hiroshi Yokozaki; Kazuaki Chayama; Wataru Yasui
Journal:  Virchows Arch       Date:  2003-08-15       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.